AN2 Therapeutics (ANTX)

• Market cap: $31.4M
• 1 day: 1.77%
• 5 days: -0.86%
• 1 month: 7.48%
• 3 months: -2.54%
• 6 months: 1.77%
• Year to date: -17.27%
• 1 year: 0.88%
• 5 years: -92.53%
• 10 years: -92.53%
• Sector: Healthcare
• Industry: Biotechnology

About: AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Employees: 36

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

80% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 5

5% less funds holding

Funds holding: 37 [Q1] → 35 (-2) [Q2]

20.34% less ownership

Funds ownership: 47.64% [Q1] → 27.3% (-20.34%) [Q2]

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

55% less capital invested

Capital invested by funds: $19.5M [Q1] → $8.73M (-$10.8M) [Q2]

100% less funds holding in top 10

Funds holding in top 10: 2 [Q1] → 0 (-2) [Q2]